Repository logo
Log In(current)
  1. Home
  2. Colleges & Schools
  3. Graduate School
  4. Doctoral Dissertations
  5. Design and Synthesis of Novel Sultams as Non-nucleoside Inhibitors of HIV Reverse Transcriptase
Details

Design and Synthesis of Novel Sultams as Non-nucleoside Inhibitors of HIV Reverse Transcriptase

Date Issued
December 1, 2013
Author(s)
LeCroix, Brian Chadwick  
Advisor(s)
David C. Baker
Additional Advisor(s)
Shawn R. Campagna
David Jenkins
Hong Guo
Permanent URI
https://trace.tennessee.edu/handle/20.500.14382/23628
Abstract

The compound 2-methyl-3-phenyl-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide (NSC 108406) was identified as an HIV-1 reverse transcriptase inhibitor by the National Cancer Institute. Using this lead, the Baker group has developed a series of analogues with various groups at the 3-position that show a spectrum of biological activities. In the end, the substituents used could not compare to the biological activity of the inhibitor efavirenz (Sustiva® [trademark]), and so it was decided to synthesize sultams with alkylethynyl substituents at the 3-position of the sultams in an attempt to mimic the activity of efavirenz.


Previous research analyzed the proposed novel sultams in the modeling program FlexiDock contained in the SYBYL package. The FlexiDock modeling performed by Riyam Kafri gave evidence for unique binding of the proposed sultams in both wild type and Y181C reverse transcriptase. Another in silico method applied to the novel sultams was the CoMFA analysis, which looks at the similarities between common compounds with known biological activities and uses this information to calculate predicted activities for untested compounds.

Synthesis of the novel ethynyl sultams is achieved by reacting the desired lithiated alkylethynyl reagent with 3-chloro-1,2-benzoisothiazole 1,1-dioxide, pseudo-saccharin chloride. Methods were designed to yield either the mono-alkylated or the bis-alkylated products. Various methods for reducing the mono-substituted compounds were applied to attempt to achieve the desired S enantiomer. Other methods resulted in the production of a racemic mixture of the reduced compounds. The reduced mono- sultams or the bisalkylated sultams are then methylated to yield the desired final product.

An aryl sultam was also synthesized in a similar method employed by Baker and co-workers by reacting saccharin with two equivalents of a Grignard reagent of 3-bromostyrene. The compound was reduced with the catalyst (R)-Cp*RhCl[(1S,2S)-p-TsNCH(C6H5)CH(C6H5)NH2] [(R)-pentalmethylcyclopentadienylrhodium chloride-(1S,2S)-p-toluenesulfonyl-1,2-diphenylethylenediamine] and alkylated with base and iodomethane. The vinyl group was reacted in a modified Simmons-Smith fashion to produce a cyclopropyl group in the meta position on the phenyl ring.

Subjects

HIV

Sultams

CoMFA Modeling

Luche reduction of im...

Disciplines
Heterocyclic Compounds
Medicinal-Pharmaceutical Chemistry
Organic Chemicals
Organic Chemistry
Degree
Doctor of Philosophy
Major
Chemistry
Embargo Date
December 15, 2014
File(s)
Thumbnail Image
Name

current_dissertation__3_.pdf

Size

3.79 MB

Format

Adobe PDF

Checksum (MD5)

65868632a13efd6317764e39b61e022a

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback
  • Contact
  • Libraries at University of Tennessee, Knoxville
Repository logo COAR Notify